These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37676986)

  • 1. Preformulation-Assisted Design of Ketorolac Tromethamine for Effective Ophthalmic Delivery.
    Abdelkader H; Fatease AA; Fathalla Z
    J Ocul Pharmacol Ther; 2023 Dec; 39(10):725-734. PubMed ID: 37676986
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 1997 Sep; 35(9):941-7. PubMed ID: 9475074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a survey of patients with ocular allergy treated with topical ketorolac tromethamine.
    Raizman MB
    Clin Ther; 1995; 17(5):882-90. PubMed ID: 8595640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis.
    Schechter BA
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):507-11. PubMed ID: 18433352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro transcorneal permeation of ketorolac from oil based ocular drops and ophthalmic ointment.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 1997 Dec; 35(12):1324-30. PubMed ID: 9567769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis.
    Tinkelman DG; Rupp G; Kaufman H; Pugely J; Schultz N
    Surv Ophthalmol; 1993; 38 Suppl():133-40. PubMed ID: 8236004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketorolac eye drops reduce inflammation and delay re-epithelization in response to corneal alkali burn in rabbits, without affecting iNOS or MMP-9.
    Lima TB; Ribeiro AP; Conceição LF; Bandarra M; Manrique WG; Laus JL
    Arq Bras Oftalmol; 2015; 78(2):67-72. PubMed ID: 25945524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of benzalkonium chloride/EDTA on the ocular bioavailability of ketorolac tromethamine following ocular instillation to normal and de-epithelialized corneas of rabbits.
    Madhu C; Rix PJ; Shackleton MJ; Nguyen TG; Tang-Liu DD
    J Pharm Sci; 1996 Apr; 85(4):415-8. PubMed ID: 8901080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
    Sandoval HP; De Castro LE; Vroman DT; Solomon KD
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery.
    Weber M; Kodjikian L; Kruse FE; Zagorski Z; Allaire CM
    Acta Ophthalmol; 2013 Feb; 91(1):e15-21. PubMed ID: 22970738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK).
    Durrie DS; Kennard MG; Boghossian AJ
    Adv Ther; 2007; 24(6):1278-85. PubMed ID: 18165210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
    Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A
    Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma caused by topical application of ketorolac.
    Sitenga GL; Ing EB; Van Dellen RG; Younge BR; Leavitt JA
    Ophthalmology; 1996 Jun; 103(6):890-2. PubMed ID: 8643243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of nonpreserved ketorolac ophthalmic solution in postoperative ocular pain following radial keratotomy.
    Brint SF; Cheetham JK; DeGryse R; Abel ML; Thompson VM; Rosenthal A
    J Cataract Refract Surg; 1999 Jan; 25(1):41-9. PubMed ID: 9888075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis.
    Donshik PC; Pearlman D; Pinnas J; Raizman MB; Tauber J; Tinkelman D; Walters TR
    Adv Ther; 2000; 17(2):94-102. PubMed ID: 11010060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of topical nonsteroidal anti-inflammatory drops and no pressure patching in the treatment of corneal abrasions. Corneal Abrasion Patching Study Group.
    Kaiser PK; Pineda R
    Ophthalmology; 1997 Aug; 104(8):1353-9. PubMed ID: 9261326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis.
    Yaylali V; Demirlenk I; Tatlipinar S; Ozbay D; Esme A; Yildirim C; Ozden S
    Acta Ophthalmol Scand; 2003 Aug; 81(4):378-82. PubMed ID: 12859265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesic efficacy and safety of nonpreserved ketorolac tromethamine ophthalmic solution following radial keratotomy. Ketorolac Radial Keratotomy Study Group.
    Yee RW
    Am J Ophthalmol; 1998 Apr; 125(4):472-80. PubMed ID: 9559732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
    Simone JN; Pendelton RA; Jenkins JE
    J Cataract Refract Surg; 1999 May; 25(5):699-704. PubMed ID: 10330648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the use of ophthalmic ketorolac tromethamine 0.4%.
    Perry HD; Donnenfeld ED
    Expert Opin Pharmacother; 2006 Jan; 7(1):99-107. PubMed ID: 16370927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.